Age-related macular degeneration (AMD) is a leading cause of visual impairment in ageing 19 populations and has no radical treatment or prevention. Although genome-wide association studies 20 (GWAS) have identified many susceptibility loci for AMD, the underlying causal genes remain 21 elusive. Here, we prioritized nine putative causal genes by integrating expression quantitative trait 22 locus (eQTL) data from blood ( = 2,765) with AMD GWAS data (16,144 cases vs. 17,832 controls) 23 and replicated six of them using retina eQTL data ( = 523). Of the six genes, altering expression of 24 cnn2, sarm1 and bloc1s1 led to ocular phenotype, impaired vision and retinal pigment epithelium 25 (RPE) loss in zebrafish. Essential photoreceptor and RPE genes were downregulated in cnn2-and 26 sarm1-knockdown zebrafishes. Through integration of GWAS and eQTL data followed by functional 27 validation, our study reveals potential roles of CNN2, SARM1 and BLOC1S1 in AMD pathogenesis 28 and demonstrates an efficient platform to prioritise causal genes for human complex diseases. 29 2 Introduction 30 Age-related macular degeneration (AMD) is an incurable blinding disorder caused by dysfunction of the 31 retinal pigment epithelium (RPE) and progressive loss of photoreceptors in the macula 1 . It results in visual 32 impairment of central vision and disability of daily life activities, such as reading, walking and face 33
regions, exert an impact on gene expression through distal regulation 10 . 48
49
With the availability of data from large-scale GWAS 5 , expression quantitative trait locus (QTL) studies 11 50 and advanced integrative statistical methods 12, 13 , we sought to test the hypothesis that genetic variants at 51 some of the susceptibility loci affect the risk of AMD through genetic regulation of transcriptional levels. 52
We used the summary-data-based Mendelian randomization (SMR) here 12 , which features the statistical 53 power because of the flexibility to utilize GWAS and eQTL data from two independent studies. We 54 subsequently used heterogeneity in dependent instruments (HEIDI) approaches to distinguish 55 causality/pleiotropy (i.e., the same causal variant(s) affecting AMD susceptibility and the expression level 56 of a gene) from linkage (i.e., two distinct causal variants in LD, one affecting AMD susceptibility and the 57 other affecting certain gene expression). This analytical framework has been successfully used in various 58 common diseases, such as diabetes, autoimmune diseases, and psychiatric disorders 14, 15 , and is for the first 59 time used in ocular diseases in this study. 60
61
We then established an experimental scheme that utilized morpholino oligonucleotide (MO)-induced 62 knockdown and/or mRNA overexpression zebrafish as an animal model to assay the putative causal genes 63 identified by the above integrative analysis (Figure 1) . Valid procedures were designed to provide 64 morphological and functional assessments of the zebrafish ocular phenotypes, thereby demonstrating the 65 functional relevance to AMD pathogenesis for these prioritised genes. Moreover, the research workflow 66 that combines integrative analysis of large-scale data in humans and functional validation in zebrafish is 67 3 general and can be used as a new paradigm to efficiently and effectively highlight susceptible genes for 68 human complex diseases and then provide insights for additional prospective therapeutic applications. 69 70 Fig. 1 Schematics of study design. First, blood eQTL and AMD GWAS data were integrated through 71 SMR and HEIDI to identify expression-phenotype associations before replications in retina or other 72 48 human tissues in GTEx. Then, functional experiments were conducted in zebrafish to measure 73 ocular sizes, light-induced behavioural patterns, qPCR of photoreceptors and RPE genes and retinal 74 immunostaining to validate the prioritised genes. 75 76 Results 77
Associating gene expression with AMD risk by an integrative analysis 78
To prioritize genes whose expression levels are associated with AMD risk, we used SMR 12 to test if a 79 variant has a joint association with AMD risk and the expression level of a gene, using GWAS and eQTL 80 summary data. The GWAS summary data were derived from a study of the International AMD Genomics 81
Consortium with 16,144 AMD cases vs. 17,832 controls 5 . The eQTL summary data were generated by the 82
Consortium for the Architecture of Gene Expression (CAGE) from a study of 36,778 gene expression 83 probes in peripheral blood of 2,765 individuals 11 . All the individuals were predominantly of European 84 ancestry, and both datasets are publicly available (URLs). And the test was performed for each of the genes 85 with at least an eQTL at PeQTL < 5e-8 (Methods). 86 4 87
In total, we identified 16 genes (tagged by 21 probes) at a genome-wide significance level 88 ( 6 5.9 10 smr P   , correcting for 8459 tests, i.e., 8459 probes with at least an eQTL at PeQTL < 5e-8) 89
( Supplementary Table 1 ). We then employed the HEIDI method 12 to reject SMR associations due to 90 linkage (removing probes with PHEIDI < 0.05) (Methods). And the LD information, required for the HEIDI 91 test, was computed from genotype data of randomly selected 20,000 individuals from European ancestry in 92 the UK Biobank 16 . Consequently, 9 genes (tagged by 12 probes) were retained (Table 1) , and some of 93 which, including BLOC1S1, PILRB, and TMEM199, have been reported in a recent study that used a 94 different strategy to integrate AMD GWAS with retinal eQTL data 17 . We found that 58.3% of the identified 95 probes were not tagging the closest genes to the top associated GWAS signals, consistent with the 96 observations from previous studies 10,12 . The eQTL variants of all the prioritised genes were common with 97 minor allele frequencies (MAF) ranging from 0.11 to 0.49. It is of note that the association of rs7212349 98 (i.e., the top associated variant for gene SARM1 with PeQTL = 1.0e-22) with AMD (PGWAS = 1.8e-7) did not 99 reach the conventional genome-wide significance threshold, suggesting a gain of power in gene discovery 100 by leveraging eQTL data, in line with previous work 12 . 101 Chr represents chromosome; A1 is the effect allele; Freq is frequency of the effect allele in the reference sample. 102
Note: BLOC1S1-RDH5 is an integrated probe in CAGE, but separated probes in EyeGex-Retina.
6

Replication of the SMR associations in retina and other tissues 104
Given possible tissue-specific genetic effects, we replicated SMR associations of the nine significant genes 105 in retina. The retinal eQTL summary data were retained from 523 postmortem subjects 17 , available in the 106 Eye Genotype Expression (EyeGex) database (URLs). Six of the nine genes were replicated at 107 3 5.6 10 smr P   (i.e., 0.05/9), a relatively high replication rate given the small sample size of the EyeGex 108 data ( Table 1 and Supplementary Figure 1) . However, for some of the replicated genes, the eQTL effects 109 were significantly different, even in opposite directions, between the retina and CAGE-blood. For instance, 110 the estimated effect of SARM1 on AMD risk was 0.301 (standard error (SE) = 0.065 and PeQTL = 4.1e-06) 111
in CAGE-blood, consistent in several other tissues (see Supplementary Figure 1 ), but was -0.351 (SE = 112 0.123 and PeQTL = 4.4e-03) in retina, suggesting that a strong tissue-specific effect and the importance to 113 replicate and interpret discovery results in disease-relevant tissue(s). 114
115
It is unclear whether AMD is a localized disease (occurring only in affected retinas) or an ocular 116 manifestation of a systemic process, since risk factors such as cigarette smoking, nutrition, and 117 cardiovascular disease have a significant impact on disease progression [19] [20] [21] [22] [23] . Thus, we conducted SMR 118 analysis for the nine genes in a wider range of tissues available in the GTEx project (Supplementary 119 Figure 1 ). Intriguingly, the results showed that PILRB, a key activator in immune function, is significant 120 across all 48 human tissues with effect sizes ranging from 0.081 (in retina) to 0.249 (in whole blood), 121
implying that systemic immune pathways may be involved in AMD pathogenesis . In fact, PILRB is not 122 an exception; all the nine genes were significant in at least two tissues and did not display obvious tissue-123 specific effects except for SARM1 shown above, consistent with the results from previous studies that cis-124 eQTL effects are largely consistent across tissues 24 . Our results also suggest that the across-tissue 125 replication rate depends heavily on the size of replication sample, supporting that using blood eQTL data 126 from large samples gains power for gene discovery. tissues. Each row represents a prioritised gene, and each column represents a tissue.
is plotted in white-purple scale. The purple color indicates more significant and the white means less 131 significant. Each tile with a number available indicates it reaches the significant threshold 5.6E-3 132 (correcting for 9 tests), with the number being the estimated SMR effect. Note that the overall mean 133 SMR p-value is decreasing towards top and right. Replication in retina is highlighted by a red 134 rectangle. 135 136 137
Knockdown of cnn2 or sarm1 led to ocular abnormalities in zebrafish 138
To validate the functional relevance of the prioritised genes to AMD pathogenesis, we sought an animal 139 model that is amenable to manipulating gene expression and that can reliably evaluate ocular phenotypes. 140
We chose zebrafish also because it has been extensively used to model ocular and other disorders 25-27 . 141 Accounting for sequence homology between human and zebrafish, we obtained 4 of the 9 prioritised genes 142 (CNN2, SARM1, BLOC1S1 replicated at PSMR < 5.6e-3 and MMP9 at PSMR < 0.05 using the retina eQTL 143 data; Table 1 ) with orthologue similarity above 60%, reported by either Ensembl or GeneCards, for 144 functional follow-up (URLs, Supplementary Table 2 ). Then, MO technology, blocking the translation 145 process of a certain mRNA, was used to knock down the corresponding gene. We observed that 146 8 downregulation of cnn2 and sarm1 at doses of 6 ng MO and 1.0 ng, respectively, led to obvious decreases 147 in axis length (by 32.5% and 21.3%, respectively) and eye area (by 48.5% and 28.5%, respectively), 148
whereas suppression of mmp9 and bloc1s1 showed no significant difference at 3 days post fertilisation 149 (dpf) (Figure 2 and Supplementary Figure 2) . 150
151
To further confirm the results, we conducted dose-dependent and rescue experiments. We found that in 152 comparison to the control, eye sizes of cnn2-MO morphants were smaller and the degree was inversely 153
proportional to the MO dose (from 4.0 to 6.0 ng) without higher mortality (Supplementary Figure 3) . For 154 the sarm1-MO morphants, abnormal ocular phenotypes occurred when the MO dose was extremely low 155 (0.50 ng), and the impact accumulated when the dose increased (from 0.50 to 4.0 ng), indicating that 156 ocular development might be sensitive to the sarm1 expression level (Supplementary Figure 4) . 157
Importantly, rescue of the smaller eyes was achieved in the mRNA and MO co-injected larvae for both 158 genes (Figure 3a,d) . Axial length was recovered by 95.8% for sarm1-MO and 91.0% for cnn2-MO 159 (Supplementary Note 1). This study provides evidence for potential roles of CNN2 and SARM1 in ocular Knockdown of cnn2 or sarm1 led to functional impairment in zebrafish 169
We then used a visual motor response (VMR) assay to evaluate the visual condition at the behavioural 170 level 5 dpf. According to a standard protocol 28 , zebrafish were placed in a 96-well plate and the locomotor 171 response to light alteration was monitored. We found that, for CNN2, three groups, including the uninjected 172 control, standard MO control and cnn2 mRNA, had a brief spike at approximately 0.20-0.22 of motor 173 activity for ON response and 0.12-0.15 for OFF response (Figure 3b, 3c) . In comparison, the response of 174 the cnn2 MO-injected group was weakened and delayed, with the peak dramatically decreasing by 61.9% 175 for lights-ON and by 78.6% at 20 s later when lights-OFF. Of note, augmentation of cnn2 mRNA with MO 176 morphants could save a visual response to 0.16 for lights-ON (recovering by 61.5%); when lights-OFF, 177 their motor activities were intensified to 0.08 (recovering by 45.5%), and the baseline was notably 178 improved. Actually, functional recovery relied on a sufficient dose of injected mRNA. Our pre-experiment 179 suggested that only partial rescue of visual function could be realized when injecting less cnn2 mRNA 180 (Supplementary Figure 5) . In addition, the SARM1 group showed similar results but with more severe 181 visual impairment (Figure 3e,f) . Notably, simple injection of sarm1 mRNA seemed to slightly promote the 182 OFF response, implying an underlying therapeutic target. Taken together, the results of the visual function 183 assays further elucidate the reduction in visual motor activities specifically caused by forced 184 downregulation of cnn2 or sarm1, indicating their essential roles in maintaining normal visual function. Considering the potential role of CNN2 and SARM1 in AMD pathophysiology, we sought to test the 199 hypothesis whether visual impairment could be attributed to defects of vital photoreceptor or RPE genes. 19.2-fold and 10.8-fold), and rpe65a (by 7.5-fold and 3.6-fold) (Figure 4) . However, regarding the mmp9 207 6.0 ng MO group, the expression levels of all six genes slightly increased by 1.2-2.4 folds. Combined with 208 the results above, the transcriptional reduction of signature genes in RPE and photoreceptors, caused by 209 downregulation of cnn2 or sarm1, is in line with ocular abnormality and visual behaviour impairments. 210
Since opsin gene expression is a determinant factor for photoreceptor degeneration 31-33 , we hypothesize 211 that downregulation of CNN2 and SARM1 are likely involved in photoreceptor degeneration during the 212 pathogenic process of AMD. markers, whereas the mmp9 group showed a slight increase. The bar plot is shown as the mean±s.e.m. 219 220
Knockdown of cnn2 or sarm1 disrupted RPE in zebrafish 221
In addition to the alteration of photoreceptors and RPE at transcriptional level, we investigated the retinal 222 morphological consequences of the knockdown by cryosection and immunostaining to further verify the 223 functional relevance of CNN2 and SARM1 with AMD pathogenesis. Using DAPI for nuclear staining, zpr-224 1 for cones, zpr-2 for RPE and zpr-3 for rods, we found that laminations were basically intact in both the 225 cnn2 6.0 ng MO group and the sarm1 1.0 ng MO group (Figure 5) . For the cnn2 6.0 ng MO group, 226 staining of cones and rods showed no apparent difference from the standard control, but RPE displayed 227 obvious disorganization and cell loss. For the sarm1 1.0 ng MO group, staining of RPE also demonstrated 228 significant deficiency, with most rods disrupted (Supplementary Figure 6) , whereas cones remained 229 complete. In fact, a prior experiment of the sarm1 6.0 ng MO group observed severe lamination disruption, 230
indicating that extreme insufficiency of sarm1 has a severely adverse impact on ocular development 231 Figure 7) . Altogether, for both cnn2 and sarm1, RPE were morphologically injured, 232 which is in accordance with a well-accepted understanding that degeneration of RPE is a fundamental 233 trigger of the cascade of events resulting in AMD pathology 34 . However, photoreceptors seemed not 234 significantly affected. A likely hypothesis is that, in a certain condition, functional changes might precede 235 morphological changes. That is, in the developmental stage, a small number of healthy RPE tissues could 236 burden delivering oxygen and metabolites, where photoreceptors maintain morphological normality but are 237 gradually functionally injured due to downregulation of cnn2 or sarm1 and photoreceptor core genes, then 238 cumulative damage tips the balance and consequently leads to degeneration 34 . 12 240 Fig. 5 Retinal architecture of cnn2-and sarm1-deficient morphants. Nuclear layers were stained 241 by DAPI in grey, and each group showed intact lamination. zpr-1, zpr-2 and zpr-3 were stained in 242 purple for each column. (a) Signals of zpr-1 and zpr-3 in the cnn2 MO 6.0 ng group were detected at 243 relatively normal levels, but the signal of zpr-2 was much lower compared with the standard control. 244 (b) Signals of zpr-3 and zpr-2 were distributed significantly less in the out layer of retina for the 245 sarm1 MO 1.0 ng group, and zpr-1 remained intact. 246 247
(Supplementary
Overexpression of bloc1s1 resulted in mild impaired ocular phenotypes in zebrafish 248
Given the significant SMR associations of BLOC1S1 in both discovery and replication analyses where the 249 effect size was positive in retina and negative in blood, we assumed that GWAS loci in BLOC1S1 affect the 250 risk of AMD by upregulating its expression. Therefore, we injected an additional zebrafish group with 251 bloc1s1 mRNA. Compared to controls, smaller eyes were observed in bloc1s1-overexpressing fishes 252 (Figure 6a) with axial length decreased by 7%. For the visual behaviour, the ON response was not 253 apparently affected, but impairment of the OFF response was observed in the bloc1s1 mRNA-injected 254 group with the peak of OFF response declined by 59.1% (Figure 6b,c) . Immunostaining results showed 255 that disruption of cones, rods and RPE in bloc1s1-overexpression group occurred (Figure 6d ) but more 256 than one half of staining repetition had no notable difference in comparison to the standard control 257 (Supplementary Figure 8) . In terms of qPCR, however, rod gene was down-regulated by 1.4-fold (P = 258 5.4e-4) and uv cone gene was up-regulated significantly by 1.3-fold (P = 0.025) but other retinal genes 259 a b 13 remained same (Supplementary Figure 9) , likely in the early stage of degeneration since a previous study 260 showed that aggregation of S-opsin (short-wavelength cone opsin, including uv opsin) is accompanied by 261 the onset of cone degeneration through activating endoplasmic reticulum (ER) stress in a murine model 31 . 262 Overall, impaired ocular phenotypes were caused by blocs1s1-overexpressing, but the impairment was 263 milder than that in the knockdown groups above. 264
265
Despite that the detrimental effects of overexpression of bloc1s1 were moderate, the phenotypic results in 266 zebrafish were in line with the estimated SMR effect in retina rather than that in blood. Here, the positive 267 SMR effect means that increased expression level of a gene is associated with increased phenotype (or 268 disease risk) and vice versa. The estimated SMR effect of BLOC1S1 was in positive and those of CNN2 269 and SARM1 were negative, predicting that increased expression level of BLOC1S1 and decreased 270 expression levels of CNN2 and SARM1 are associated with increased AMD risk. In a word, the prediction 271 from SMR and HEIDI analysis was validated in zebrafish that knockdown of cnn2 and sarm1 and 272 overexpression of bloc1s1 caused ocular abnormalities. Immunostaining of bloc1s1-mRNA zebrafish retinae showed apparently low expression for zpr-1, zpr- In this study, we aimed to shed light on the biological knowledge expected from integrated analysis of 283 AMD GWAS and eQTL summary data. Initially, we identified 9 putative causal genes for AMD using the 284 SMR and HEIDI methods based on a blood eQTL dataset (Table 1) , and subsequently replicated 6 of the 9 285 genes using a retina eQTL dataset (Table 1 and Supplementary Figure 1) . We also tested the 9 genes in 286 48 other tissues using the GTEx eQTL data and showed that the across-tissue replication rate depended 287 heavily on the size of replication sample (Supplementary Figure 1) . We carried 4 of the 9 genes forward 288 for functional assay in zebrafish and for the first time demonstrated the functional relevance of CNN2, 289 SARM1 and BLOC1S1 to AMD. Injection of respective cnn2 MO, sarm1 MO and bloc1s1 mRNA in 290 zebrafish larvae exhibited different degrees of ocular defects (Figures 2 and 6) , vision loss (Figures 3 and  291   6) , relatively low transcription of essential photoreceptor and/or RPE genes (Figure 4) and RPE 292 degeneration (Figures 5 and 6) . Importantly, knockdown-induced phenotypes could be rescued by 293 augmentation of corresponding mRNA (Figure 3) , indicating the potential as targets to design new 294 treatments. Finally, the phenotypic effects of alternating transcription of the prioritised genes in zebrafish 295 were in line with the directions of estimated SMR effects in human retinas. All these results provide strong 296 evidence supporting the potential role of CNN2, SARM1 and BLOC1S1 in AMD pathogenesis. 297
298
There is no denying that the study has some limitations. First, we used a large blood eQTL data set ( = 299 2,765) for discovery and a relatively small retina eQTL data set ( = 523) for replication, following the 300 suggestion from a recent study 14 . This strategy would have missed genes with a cis-eQTL effect in retina 301 but not in blood. However, we considered that if cis-eQTL effects are similar across tissues 18,24 , using a 302 blood eQTL data set of large sample size could increase the power of gene discovery in comparison to 303 using a retina eQTL data set of small sample size. In addition, blood is much more accessible than retina so 304 that the growth of eQTL data from blood is expected to be faster than that from retina, suggesting that the 305 power of our analysis strategy could be substantially improved in the future by leveraging blood eQTL 306 data sets with sample sizes of orders of magnitude larger than that used in this study 35 . 307 308 Second, zebrafish is an ideal but not perfect animal model. AMD is an age-related disease. However, 309 zebrafish larvae were studied instead of elder zebrafish because the most efficient duration of MO-310 mediated knockdown effects is the first two or three days of development, and efficiencies decrease later 36 , 311
rendering it difficult to observe age-related morphological and functional changes. Generating a primate 312 AMD model is the most scientifically valid since humans or primates are the only mammals with a macula 313 and foveal centralis, where AMD manifests, but it is extremely challenging in particular with respect to 314 costs and time scale of the experiment. Instead, an important role of the zebrafish models is to serve as an 315 efficient screening test to narrow down the most plausible causal genes through our comprehensive 316 evaluation approaches. And the robust ocular changes of the prioritised genes, even in larvae time, should 317 15 not be underestimated. It is acknowledged that individual SNPs generally confer small effects on gene 318 expression 11 , but MO interventions dramatically eliminate transcriptional levels, resulting in more severe 319 and noticeable phenotypes. Moreover, accumulating evidence indicates that the origins of age-related 320 disorders occur during foetal life 37, 38 , and AMD should not be an exception. 321
322
Third, the genetic mechanisms of gene regulation and the relationship of gene regulation to AMD 323 manifestation remain a mystery. Hypotheses of non-coding SNPs that influence gene expression include 324 transcriptional, posttranscriptional, or posttranslational process 9 , such as non-coding RNA function or 325 histone modification, allowing for more specific regulatory mechanistic studies. Of note, it is more 326 important to identify the causal gene than the causal variant because the ultimate goal is to identify the 327 causal gene, which can correspond to multiple causal variants. A mass of downstream research is required 328
to understand the underlying molecular mechanisms. Intriguing clues include compelling biology such as 329 inflammatory response and lipid metabolism and underlying overlapping pathophysiology with other age-330 related diseases for genes such as CNN2, PILRB and ABCA7 that are also located at risk loci for late onset 331
Alzheimer's disease (AD) (Supplementary Table 3 for the description of each prioritised gene). 332
333
In summary, we performed an integrative data analysis that efficiently pinpointed novel susceptibility 334 genes for AMD, and demonstrated the functional relevance of CNN2, SARM1 and BLOC1S1 to the disease 335 using zebrafish models. The gene discovery procedure, combining statistical analysis of large-scale data 336 and experimental validation, can be applied to other complex disorders to fill the knowledge gaps between 337 genetic variants and phenotypes. 338 339
Online Methods 340
Data used for the integrative analysis 341
The GWAS summary data used in this study were derived from the latest and largest AMD GWAS meta-342 analysis 5 (see URLs section), consisting of 16,144 advanced AMD patients and 17,832 controls of 343 predominantly European ancestry. The total number of SNPs was up to 12 million. The SNP effects were 344 expressed as log odds ratios. Because the SNP allele frequency was not available, we estimated the allele 345 frequencies using the UK Biobank data 16 SMR and HEIDI analyses were developed to identify genes whose expression levels were associated with 359 a complex trait because of pleiotropy/causality (i.e., the trait and gene expression are associated due to the 360 same set of causal variants at a locus) 12 . First, the SMR test takes the top associated cis-eQTL of the gene 361 as an instrumental variable to test for association of a transcript (as an exposure) with AMD (as an 362 outcome). An SMR estimate of the effect of gene expression on AMD is the ratio of the estimated effect of 363 the instrument on a transcript (eQTL effect) and that on the disease (GWAS effect). The standard error 364 (SE) of the SMR effect is computed using the Delta method, and the significance of the effect is assessed 365 by the Wald test. To exclude the SMR associations due to linkage (i.e., the trait and gene expression are 366 associated due to distinct set of causal variants in LD), the HEIDI analysis uses multiple SNPs in a cis-367 eQTL region to test against the null hypothesis that the trait is associated with gene expression because of 368 the same set of underlying causal variants (pleiotropy/causality). Under the null, the SMR effects estimated 369 using different eQTL SNPs in the cis region are expected to be the same. Significant heterogeneity in SMR 370 effects detected at different SNPs in LD with the top associated cis-eQTL would be considered as linkage 371 and rejected from the analysis. 372 373
Morpholino, mRNA rescue and overexpression experiments 374
For the cnn2 mRNA rescue experiment, we generated zebrafish cDNA from total RNA using RT-PCR on a 375 full-length cnn2 fragment. For the sarm1 mRNA rescue and bloc1s1 overexpression study, we attained 376 specific cDNA from the pUC57 vector cloned into template cDNA sequences of sarm1 or bloc1s1, which 377 were obtained through oligoribonucleotide synthesis (Sangon Biotech, Shanghai, China). The 378 amplification primers of cnn2 included the forward (5'-379 TAATACGACTCACTATAGGGGCCACCATGTCTTCGCAG-3') and the reverse (5'-380 TTAGTAATCTTGGCCGTCGTCCTGATAGC-3'); sarm1 included the forward (5'-381 TAATACGACTCACTATAGGGGCCACCATGTTTTTGTCCCTCG-3') and the reverse (5'-382 CTACTTCTTTTGTGGCTCTTTTTTGTCCG-3'); bloc1s1, included the forward (5'-383 TAATACGACTCACTATAGGGGCCACCATGCTCTCGCGG-3') and the reverse (5'-384 TCATGTGGATGCCGGCTGGAC-3'); they all flank the T7 promoter sequence (5'-385 TAATACGACTCACTATAGGG-3') and enhancing sequence (Kozak). PCR template DNA was purified 386 using the QIAquick PCR Purification Kit (Qiagen, Germany). Capped and tailed full-length mRNA was 387 then synthesized using an mMESSAGE mMACHINE™ T7 ULTRA Transcription Kit (Invitrogen, 388
Carlsbad, CA) before purification using the RNeasy Mini Kit (Qiagen, Germany) following the 389 manufacturer's protocols. Rescue mRNAs were co-injected with MO into the one-cell stage embryos. For 390 overexpression, corresponding mRNAs were injected into one-to two-cell stage embryos. 391 392 Measurement of eye parameters and body length 393
